Christopher Jacklin

Biotech entrepreneur working to scale up and standardize the use of 3D cell models in pharmaceutical drug development. Passionate about human health and the future of healthcare.

3D Bone and Cartilage Models to Understand Tissue Regeneration

Dec 9, 2024

•

10 min read

3D Bone and Cartilage Models to Understand Tissue Regeneration

Christopher Jacklin

Drug Development

Ultra-Miniaturized Primary Hepatocyte Spheroids for Early-Stage Drug Discovery

Nov 4, 2024

•

15 min read

Ultra-Miniaturized Primary Hepatocyte Spheroids for Early-Stage Drug Discovery

Christopher Jacklin

3D Models of the Most Communicative Organ in the Body: Fat

Jul 1, 2024

•

14 min read

3D Models of the Most Communicative Organ in the Body: Fat

Christopher Jacklin

Jun 10, 2024

•

13 min read

The Key Advancing 3D Culture

Christopher Jacklin

May 13, 2024

•

14 min read

A vision for animal-free drug testing

Christopher Jacklin

Bioprinting, M&A blunders, and how to tell if a biotech startup is destined to fail

Apr 2, 2024

•

16 min read

Bioprinting, M&A blunders, and how to tell if a biotech startup is destined to fail

Christopher Jacklin

Christopher Jacklin

3D Bone and Cartilage Models to Understand Tissue Regeneration

Ultra-Miniaturized Primary Hepatocyte Spheroids for Early-Stage Drug Discovery

3D Models of the Most Communicative Organ in the Body: Fat

The Key Advancing 3D Culture

A vision for animal-free drug testing

Bioprinting, M&A blunders, and how to tell if a biotech startup is destined to fail

The Future of 3D Cell Culture

Home